OKYO.L Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 mai 2023 @ 17:35):

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom...

Stats
Dagens volum	19 575
Gjennomsnittsvolum	538 135
Markedsverdi	23.22M
EPS	£-0.000591 ( Q2 \| 2020-09-30 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.400 (Sector) 0 (Industry) 0
ATR14	£0.371 (26.50%)

AMYT.L -11.73%

APH.L 0.51%

AVCT.L 1.18%

AZN.L -0.31%

BMK.L 7.59%

BVXP.L -2.16%

C4XD.L 27.32%

CIR.L 0.00%

CLIN.L 0.11%

DEST.L -2.51%

DPH.L 0.05%

EAH.L 2.40%

ERGO.L 0.15%

ETX.L -6.74%

EVG.L 2.25%

FAB.L -1.59%

FARN.L -5.08%

FUM.L 1.58%

GDR.L 3.09%

GNS.L 1.45%

GSK.L -0.48%

HCM.L -0.36%

HEMO.L 0.53%

HIK.L -0.90%

IMM.L -1.15%

INDV.L 0.24%

IXI.L -5.25%

MTPH.L 1 794.74%

MXCT.L -2.17%

N4P.L -4.71%

NCYT.L -2.48%

NFX.L -4.71%

OBD.L 0.90%

OKYO.L -24.32%

ONC.L 0.45%

OPTI.L -3.75%

OVB.L -15.56%

OXB.L 2.58%

PRM.L -4.82%

PRTC.L 1.54%

PYC.L -6.25%

REDX.L 31.58%

RENE.L -2.17%

SAR.L 8.67%

SCLP.L -1.81%

SLN.L -0.93%

SNG.L 3.48%

STX.L 2.70%

TILS.L 8.33%

TRX.L -1.15%

VAL.L 0.00%

VEC.L 0.00%

Volum Korrelasjon

Lang: 0.26 (neutral)

Kort: -0.60 (weak negative)

Signal:(35.253) Neutral

OKYO Pharma Ltd Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

OKYO Pharma Ltd Korrelasjon - Valuta/Råvare

0.23
( neutral )

0.41
( neutral )

0.66
( moderate )

-0.20
( neutral )

-0.42
( neutral )

0.31
( neutral )

OKYO Pharma Ltd Økonomi

Annual	2022
Omsetning:	£0
Bruttogevinst:	£0 (0.00 %)
EPS:	£-0.00420

FY	2022
Omsetning:	£0
Bruttogevinst:	£0 (0.00 %)
EPS:	£-0.00420

FY	2021
Omsetning:	£0.00
Bruttogevinst:	£0.00 (0.00 %)
EPS:	£-0.00446

FY	2020
Omsetning:	£0.00
Bruttogevinst:	£0.00 (0.00 %)
EPS:	£-0.00200

Financial Reports:

No articles found.

OKYO Pharma Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

OKYO Pharma Ltd

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.